lunes, 15 de marzo de 2021

Curcumin: a therapeutic strategy in cancers by inhibiting the canonical WNT/β-catenin pathway | Journal of Experimental & Clinical Cancer Research | Full Text

Curcumin: a therapeutic strategy in cancers by inhibiting the canonical WNT/β-catenin pathway | Journal of Experimental & Clinical Cancer Research | Full Text

No hay comentarios:

Publicar un comentario